全文获取类型
收费全文 | 2134篇 |
免费 | 202篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 121篇 |
妇产科学 | 47篇 |
基础医学 | 340篇 |
口腔科学 | 94篇 |
临床医学 | 198篇 |
内科学 | 516篇 |
皮肤病学 | 55篇 |
神经病学 | 95篇 |
特种医学 | 203篇 |
外科学 | 159篇 |
综合类 | 113篇 |
预防医学 | 125篇 |
眼科学 | 20篇 |
药学 | 139篇 |
中国医学 | 17篇 |
肿瘤学 | 138篇 |
出版年
2023年 | 16篇 |
2022年 | 8篇 |
2021年 | 32篇 |
2020年 | 32篇 |
2019年 | 31篇 |
2018年 | 42篇 |
2017年 | 54篇 |
2016年 | 63篇 |
2015年 | 54篇 |
2014年 | 94篇 |
2013年 | 126篇 |
2012年 | 96篇 |
2011年 | 95篇 |
2010年 | 106篇 |
2009年 | 104篇 |
2008年 | 84篇 |
2007年 | 114篇 |
2006年 | 84篇 |
2005年 | 88篇 |
2004年 | 66篇 |
2003年 | 55篇 |
2002年 | 52篇 |
2001年 | 75篇 |
2000年 | 62篇 |
1999年 | 43篇 |
1998年 | 79篇 |
1997年 | 70篇 |
1996年 | 67篇 |
1995年 | 64篇 |
1994年 | 52篇 |
1993年 | 47篇 |
1992年 | 34篇 |
1991年 | 26篇 |
1990年 | 36篇 |
1989年 | 33篇 |
1988年 | 37篇 |
1987年 | 22篇 |
1986年 | 23篇 |
1985年 | 19篇 |
1984年 | 12篇 |
1983年 | 14篇 |
1982年 | 9篇 |
1981年 | 5篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 15篇 |
1975年 | 12篇 |
1974年 | 3篇 |
排序方式: 共有2390条查询结果,搜索用时 203 毫秒
1.
Kuo‐Hwa Chiang Jiunn‐Min Shieh Chih‐Jie Shen Ting‐Wei Chang Pei‐Ting Wu Jinn‐Yuan Hsu Jhih‐Peng Tsai Wen‐Chang Chang Ben‐Kuen Chen 《Cancer science》2020,111(6):2004-2015
Epidermal growth factor receptor (EGFR) expression and activation are the major causes of metastasis in cancers such as head and neck squamous cell carcinoma (HNSCC). However, the reciprocal effect of EGF‐induced COX‐2 and angiopoietin‐like 4 (ANGPTL4) on HNSCC metastasis remains unclear. In this study, we revealed that the expression of ANGPTL4 is essential for COX‐2‐derived prostaglandin E2 (PGE2)‐induced tumor cell metastasis. We showed that EGF‐induced ANGPTL4 expression was dramatically inhibited with the depletion and inactivation of COX‐2 by knockdown of COX‐2 and celecoxib treatment, respectively. Prostaglandin E2 induced ANGPTL4 expression in a time‐ and dose‐dependent manners in various HNSCC cell lines through the ERK pathway. In addition, the depletion of ANGPTL4 and MMP1 significantly impeded the PGE2‐induced transendothelial invasion ability of HNSCC cells and the binding of tumor cells to endothelial cells. The induction of molecules involved in the regulation of epithelial‐mesenchymal transition was also dependent on ANGPTL4 expression in PGE2‐treated cells. The depletion of ANGPTL4 further blocked PGE2‐primed tumor cell metastatic seeding of lungs. These results indicate that the EGF‐activated PGE2/ANGPTL4 axis enhanced HNSCC metastasis. The concurrent expression of COX‐2 and ANGPTL4 in HNSCC tumor specimens provides insight into potential therapeutic targets for the treatment of EGFR‐associated HNSCC metastasis. 相似文献
2.
Hester F Shieh Sarah A Tracy Charles R Hong Alexander V Chalphin Azra Ahmed Lucas Rohrer David Zurakowski Dario O Fauza 《Journal of pediatric surgery》2019,54(2):293-296
Purpose
Transamniotic stem cell therapy (TRASCET) with select mesenchymal stem cells (MSCs) has been shown to induce partial or complete skin coverage of spina bifida in rodents. Clinical translation of this emerging therapy hinges on its efficacy in larger animal models. We sought to study TRASCET in a model requiring intra-amniotic injections 60 times larger than those performed in the rat.Methods
Rabbit fetuses (n?=?65) with surgically created spina bifida were divided into three groups. One group (untreated) had no further manipulations. Two groups received volume-matched intra-amniotic injections of either saline or a concentrated suspension of amniotic fluid MSCs (afMSCs) at the time of operation. Infused afMSCs consisted of banked heterologous rabbit afMSCs with mesenchymal identity confirmed by flow cytometry, labeled with green fluorescent protein. Defect coverage at term was blindly categorized only if the presence of a distinctive neoskin was confirmed histologically. Statistical comparisons were by logistic regression and the likelihood ratio test.Results
Among survivors with spina bifida (n?=?19), there were statistically significant higher rates of defect coverage (all partial) in the afMSC group when compared with the saline and untreated groups (0–50%; p?=?0.022–0.036), with no difference between the saline and untreated groups (p?=?1.00). Donor afMSCs were identified locally, though sparsely and not in the neoskin.Conclusions
Concentrated intra-amniotic injection of amniotic mesenchymal stem cells can induce partial coverage of experimental spina bifida in a leporine model. Transamniotic stem cell therapy may become a feasible strategy in the prenatal management of spina bifida.Level of Evidence
N/A (animal and laboratory study). 相似文献3.
Jeremy D. Woods Negar Khanlou Hane Lee Rebecca Signer Perry Shieh Johnathan Chen Matthew Herzog Christina Palmer Julian Martinez-Agosto Undiagnosed Diseases Network Stanley F. Nelson 《Neuropathology》2020,40(3):302-307
Biallelic pathogenic variants in the gene PYROXD1 have recently been described to cause early-onset autosomal recessive myopathy. Myopathy associated with PYROXD1 pathogenic variants is rare and reported in only 17 individuals. Known pathogenic variants in PYROXD1 include missense, insertion and essential splice-site variants. Here we describe a consanguineous family of individuals affected with late-onset myopathy and homozygous PYROXD1 missense variants (NM_024854.5:c.464A>G [p.Asn155Ser]) expanding our understanding of the possible disease phenotypes of PYROXD1-associated myopathy. 相似文献
4.
5.
6.
Routine invasive versus selective invasive strategies for Non‐ST‐elevation acute coronary syndromes: An Updated meta‐analysis of randomized trials 下载免费PDF全文
7.
Long‐term outcomes with first‐ vs. second‐generation drug‐eluting stents in saphenous vein graft lesions 下载免费PDF全文
Nagendra R. Pokala BS Rohan V. Menon BS Siddharth M. Patel BS George Christopoulos MD Georgios E. Christakopoulos MD Anna P. Kotsia MD Bavana V. Rangan BDS MPH Michele Roesle RN Shuaib Abdullah MD Jerrold Grodin MD Dharam J. Kumbhani MD SM MRCP Jeffrey Hastings MD Subhash Banerjee MD Emmanouil S. Brilakis MD PhD 《Catheterization and cardiovascular interventions》2016,87(1):34-40
8.
9.
Geoffrey W. Birrell Marina Chavchich Arba L. Ager Hong-Ming Shieh Gavin D. Heffernan Wenyi Zhao Peter E. Krasucki Kurt W. Saionz Jacek Terpinski Guy A. Schiehser Laura R. Jacobus G. Dennis Shanks David P. Jacobus Michael D. Edstein 《Antimicrobial agents and chemotherapy》2015,59(1):170-177
4-(tert-Butyl)-2-((tert-butylamino)methyl)-6-(6-(trifluoromethyl)pyridin-3-yl)-phenol (JPC-2997) is a new aminomethylphenol compound that is highly active in vitro against the chloroquine-sensitive D6, the chloroquine-resistant W2, and the multidrug-resistant TM90-C2B Plasmodium falciparum lines, with 50% inhibitory concentrations (IC50s) ranging from 7 nM to 34 nM. JPC-2997 is >2,500 times less cytotoxic (IC50s > 35 μM) to human (HepG2 and HEK293) and rodent (BHK) cell lines than the D6 parasite line. In comparison to the chemically related WR-194,965, a drug that had advanced to clinical studies, JPC-2997 was 2-fold more active in vitro against P. falciparum lines and 3-fold less cytotoxic. The compound possesses potent in vivo suppression activity against Plasmodium berghei, with a 50% effective dose (ED50) of 0.5 mg/kg of body weight/day following oral dosing in the Peters 4-day test. The radical curative dose of JPC-2997 was remarkably low, at a total dose of 24 mg/kg, using the modified Thompson test. JPC-2997 was effective in curing three Aotus monkeys infected with a chloroquine- and pyrimethamine-resistant strain of Plasmodium vivax at a dose of 20 mg/kg daily for 3 days. At the doses administered, JPC-2997 appeared to be well tolerated in mice and monkeys. Preliminary studies of JPC-2997 in mice show linear pharmacokinetics over the range 2.5 to 40 mg/kg, a low clearance of 0.22 liters/h/kg, a volume of distribution of 15.6 liters/kg, and an elimination half-life of 49.8 h. The high in vivo potency data and lengthy elimination half-life of JPC-2997 suggest that it is worthy of further preclinical assessment as a partner drug. 相似文献
10.
Carol Shieh Michael T. Weaver Kathleen M. Hanna Kathleen Newsome Mulubrhan Mogos 《Journal of community health nursing》2015,32(4):199-211
This study examined the association of self-efficacy and self-regulation with nutrition and exercise behaviors. The study used a cross-sectional design and included 108 participants (54 men, 54 women). Nutrition behaviors (fruit/vegetable consumption, dinner cooking, and restaurant eating) and exercise were measured using total days in last week a behavior was reported. Instruments measuring self-efficacy and self-regulation demonstrated excellent Cronbach’s alphas (.93–.95). Path analysis indicated only fruit/vegetable consumption and exercise were associated with self-efficacy and self-regulation. Self-regulation showed direct association with fruit/vegetable consumption and exercise, but self-efficacy had direct association only with exercise. Self-efficacy and self-regulation should be strategically used to promote health behaviors. 相似文献